UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 39

Sortiert nach

Characterization of latently infected EBV+ antibody-secreting B cells isolated from ovarian tumors and malignant ascites

Frontiers in immunology, 2024-07, Vol.15, p.1379175

2024

Volltextzugriff (PDF)

Intestinal Radiation Protection and Mitigation by Second-Generation Probiotic Lactobacillus-reuteri Engineered to Deliver Interleukin-22

International journal of molecular sciences, 2022-05, Vol.23 (10), p.5616

2022

Volltextzugriff (PDF)

MUC1 positive, Kras and Pten driven mouse gynecologic tumors replicate human tumors and vary in survival and nuclear grade based on anatomical location

PloS one, 2014-07, Vol.9 (7), p.e102409-e102409

2014

Volltextzugriff (PDF)

Folate Receptor-Targeted Multimodality Imaging of Ovarian Cancer in a Novel Syngeneic Mouse Model

Molecular pharmaceutics, 2015-02, Vol.12 (2), p.542-553

2015

Volltextzugriff (PDF)

MUC1 Immunobiology: From Discovery to Clinical Applications

Advances in Immunology, 2004, Vol.82, p.249-293

2004

Volltextzugriff (PDF)

Targeted treatment of recurrent platinum-resistant ovarian cancer: current and emerging therapies

Cancer management and research, 2011, Vol.3 (default), p.25-38

2011

Volltextzugriff (PDF)

A conditional mouse model for human MUC1-positive endometriosis shows the presence of anti-MUC1 antibodies and Foxp3+ regulatory T cells

Disease models & mechanisms, 2009-11, Vol.2 (11-12), p.593-603

2009

Volltextzugriff (PDF)

Lactobacillus reuteri Releasing IL-22 (LR-IL-22) Facilitates Intestinal Radioprotection for Whole-Abdomen Irradiation (WAI) of Ovarian Cancer

Radiation research, 2022-07, Vol.198 (1), p.89

2022

Volltextzugriff (PDF)

The Mechanism of Unresponsiveness to Circulating Tumor Antigen MUC1 Is a Block in Intracellular Sorting and Processing by Dendritic Cells

The Journal of immunology (1950), 2000-10, Vol.165 (7), p.3730-3741

2000

Volltextzugriff (PDF)

Cancer-associated MSC drive tumor immune exclusion and resistance to immunotherapy, which can be overcome by Hedgehog inhibition

Science advances, 2021-11, Vol.7 (46), p.eabi5790-eabi5790

2021

Volltextzugriff (PDF)

Abstract 3208: Chemo-induced biology of PD-L1 and in vivo combination immune therapy for ovarian cancer

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.3208-3208

2016

Volltextzugriff (PDF)

Tumor-associated MUC1 glycopeptide epitopes are not subject to self-tolerance and improve responses to MUC1 peptide epitopes in MUC1 transgenic mice

Biological chemistry, 2009-07, Vol.390 (7), p.611-618

2009

Volltextzugriff (PDF)

Complex carbohydrates are not removed during processing of glycoproteins by dendritic cells: processing of tumor antigen MUC1 glycopeptides for presentation to major histocompatibility complex class II-restricted T cells

The Journal of experimental medicine, 2002-12, Vol.196 (11), p.1435-1446

2002

Volltextzugriff (PDF)

Inflammatory biomarker in adipose stem cells of women with endometrial cancer

Biomarkers in medicine, 2018-09, Vol.12 (9), p.945-952

2018

Volltextzugriff (PDF)

Restraint stress and stress hormones significantly impact T lymphocyte migration and function through specific alterations of the actin cytoskeleton

Brain, behavior, and immunity, 2011-08, Vol.25 (6), p.1187-1196

2011

Volltextzugriff (PDF)

Restraint and Social Isolation Stressors Differentially Regulate Adaptive Immunity and Tumor Angiogenesis in a Breast Cancer Mouse Model

Cancer and clinical oncology, 2017-05, Vol.6 (1), p.12-24

2017

Volltextzugriff (PDF)

MUC1 in endometriosis and ovarian cancer

Immunologic research, 2006-01, Vol.36 (1-3), p.229-236

2006

Volltextzugriff (PDF)

Plasma MicroRNAs as Novel Biomarkers for Endometriosis and Endometriosis-Associated Ovarian Cancer - Response

Clinical cancer research, 2013-04, Vol.19 (12), p.3326-3326

2013

Volltextzugriff (PDF)

Phase I trial combining chemokine-targeting with loco-regional chemo-immunotherapy for recurrent, platinum-sensitive ovarian cancer shows induction of CXCR3 ligands and markers of type 1 immunity

Clinical cancer research, 2022-05, Vol.28 (10), p.2038-2049

2022

Volltextzugriff (PDF)

Abstract B33: Neoepitope peptide vaccines and immune checkpoint blockade in a new preclinical ovarian cancer model

Clinical cancer research, 2018-08, Vol.24 (15_Supplement), p.B33-B33

2018

Volltextzugriff (PDF)

Glycoprotein tumor antigens for immunotherapy of breast cancer

Breast disease, 2004, Vol.20, p.73

2004

Volltextzugriff (PDF)

Abstract 4976: Novel ovarian cancer transplantable models generated from MUC1KrasPten tumors show in vitro and in vivo heterogeneity

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.4976-4976

2014

Volltextzugriff (PDF)

Genetically Engineered Probiotic ILimosilactobacillus reuteri/I Releasing IL-22 Modifies the Tumor Microenvironment, Enabling Irradiation in Ovarian Cancer

Cancers, 2024-01, Vol.16 (3)

2024

Volltextzugriff (PDF)

Release of Interferon-β following Whole Abdominal Irradiation

Cancers, 2023-03, Vol.15 (6)

2023

Volltextzugriff (PDF)

Abstract POSTER-THER-1434: Intraperitoneal anti-PD-L1 increases survival in a novel ovarian cancer model and its in vivo efficacy is influenced by baseline anti-tumor immunity of the host

Clinical cancer research, 2015-08, Vol.21 (16_Supplement), p.POSTER-THER-1434-POSTER-THER-1434

2015

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(39)

Sprache

Englisch
(39)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Characterization of latently infected EBV+ antibody-secreting B cells isolated from ovarian tumors and malignant ascites

Intestinal Radiation Protection and Mitigation by Second-Generation Probiotic Lactobacillus-reuteri Engineered to Deliver Interleukin-22

MUC1 positive, Kras and Pten driven mouse gynecologic tumors replicate human tumors and vary in survival and nuclear grade based on anatomical location

Folate Receptor-Targeted Multimodality Imaging of Ovarian Cancer in a Novel Syngeneic Mouse Model

MUC1 Immunobiology: From Discovery to Clinical Applications

Targeted treatment of recurrent platinum-resistant ovarian cancer: current and emerging therapies

A conditional mouse model for human MUC1-positive endometriosis shows the presence of anti-MUC1 antibodies and Foxp3+ regulatory T cells

Lactobacillus reuteri Releasing IL-22 (LR-IL-22) Facilitates Intestinal Radioprotection for Whole-Abdomen Irradiation (WAI) of Ovarian Cancer

The Mechanism of Unresponsiveness to Circulating Tumor Antigen MUC1 Is a Block in Intracellular Sorting and Processing by Dendritic Cells

Cancer-associated MSC drive tumor immune exclusion and resistance to immunotherapy, which can be overcome by Hedgehog inhibition

Abstract 3208: Chemo-induced biology of PD-L1 and in vivo combination immune therapy for ovarian cancer

Tumor-associated MUC1 glycopeptide epitopes are not subject to self-tolerance and improve responses to MUC1 peptide epitopes in MUC1 transgenic mice

Complex carbohydrates are not removed during processing of glycoproteins by dendritic cells: processing of tumor antigen MUC1 glycopeptides for presentation to major histocompatibility complex class II-restricted T cells

Inflammatory biomarker in adipose stem cells of women with endometrial cancer

Restraint stress and stress hormones significantly impact T lymphocyte migration and function through specific alterations of the actin cytoskeleton

Restraint and Social Isolation Stressors Differentially Regulate Adaptive Immunity and Tumor Angiogenesis in a Breast Cancer Mouse Model

MUC1 in endometriosis and ovarian cancer

Plasma MicroRNAs as Novel Biomarkers for Endometriosis and Endometriosis-Associated Ovarian Cancer - Response

Phase I trial combining chemokine-targeting with loco-regional chemo-immunotherapy for recurrent, platinum-sensitive ovarian cancer shows induction of CXCR3 ligands and markers of type 1 immunity

Abstract B33: Neoepitope peptide vaccines and immune checkpoint blockade in a new preclinical ovarian cancer model

Glycoprotein tumor antigens for immunotherapy of breast cancer

Abstract 4976: Novel ovarian cancer transplantable models generated from MUC1KrasPten tumors show in vitro and in vivo heterogeneity

Genetically Engineered Probiotic ILimosilactobacillus reuteri/I Releasing IL-22 Modifies the Tumor Microenvironment, Enabling Irradiation in Ovarian Cancer

Release of Interferon-β following Whole Abdominal Irradiation

Abstract POSTER-THER-1434: Intraperitoneal anti-PD-L1 increases survival in a novel ovarian cancer model and its in vivo efficacy is influenced by baseline anti-tumor immunity of the host

Aktive Filter

Suchergebnisse filtern